Medical Mycology

Article	Citations
Evaluation of the drug–drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort	36
Landscape of in situ cytokine expression, soluble C-type lectin receptors, and vitamin D in patients with recurrent vulvovaginal candidiasis	28
P216 Rare isolates from subcutaneous mycotic lesions; A study from tertiary care center in Chhattisgarh, India	27
Invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island (2018–2022): An observational study	27
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis	26
P196 A rare presentation of subcutaneous Entomophthoramycosis	26
P361 Demystifying the NIH grant application process for international investigators	25
S2.2d Evaluation of new tools for the diagnosis of histoplasmosis	22
S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain	22
P422 EQUAL PCP Score 2022—an ECMM score derived from current guidelines to measure QUAlity of clinical Pneumocystis Pneumonia management	20
P373 Does biofilm forming capacity of Candida tropicalis vary with echinocandin susceptibility?	19
S5.1b Antifungal r esistance	19
P335 Genome plasticity in Candida albicans : acutting-edge strategy for evolution, adaptation, and survival	19
S1.3c Diversity and hybridization in Malassezia furfur	19
Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis	18
Clinical characteristics and outcomes of pancreatic fungal infection in patients with necrotizing pancreatitis	18
Prevalence of azole-resistant Aspergillus fumigatus and other aspergilli in the environment from Argentina	18
Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants	18
Superficial fungal infections in the south of France—is fusariosis the next emergent onychopathy?	17
Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa	17
Inhibitory effect of polyunsaturated fatty acids alone or in combination with fluconazole on Candida krusei biofilms in vitro and in Caenorhabditis elegans	16
P019 A 5-year study on prevalence and molecular determinants of fluconazole -resistance in C. parapsilosis spp. complex	16
A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole	16
P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study	15
P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India	15

OUP accepted manuscript	14
Novel in vivo observations of luliconazole 5% nail solution for onychomycosis: An ultrastructural study	14
Knowledge and regulation on fungal contamination of sand and water: Progress report and perspectives	14
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo	13
P088 Molecular identification and antifungal susceptibility of pathogenic yeasts from the China Antifungal Resistance Surveillance Trial (CARST-fungi) Study	13
S10.4c Successful treatment of mucormycosis in hematological diseases	13
P344 Automatic detection of pneumocystis jirovecii in microscope images: adeep learning-based approach	12
P094 Atypical cutaneous manifestations of sporotrichosis in Brazil	12
P466 Isolation of Cryptococcus neoformans and other yeast from pigeon droppings in Khartoum state, Sudan	12
P086 Clinical outcome and in vitro antifungal susceptibility of clinical isolates of rhino-orbito-cerebral mycosis associated with post COVID 19 from North India	12
P478 Identification of clinical Candida isolates using maldi-tof-ms and their antifungal susceptibility profile—a study from tertiary care pediatric hospital in noida	12
S9.5d Genotyping of Malassezia species from seborrheic dermatitis/dandruff patients	12
P309 Clonal outbreak of Trichophyton tonsurans causing tinea capitis among wrestlers in Beijing, China	11
P192 Investigating the link between pleomorphism and virulence in Cryptococcus	11
P212 Fatal invasive aspergillosis in a child with Chronic Granulomatous disease; a case report	11
P148 Emerging and cryptic Aspergillus species isolated from hospitalized patients with underlying primary immunodeficiencies	11
P355 Pitfalls in medical mycology in India	10
P382 Scalp fungal microbiome and sebum composition in males with and without androgenetic alopecia	10
S5.5d SARS-CoV-2 associated invasive fungal sinus infections; the Sri Lankan perspective	10
S2.2a African histoplasmosis	10
S3.4e Unraveling the role of DOG genes in a novel alternative pathway of glycerol biosynthesis in Candida albicans and its influence on virulence	9
Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance	9
Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis	9
S1.3d The human pathobiont Malassezia furfur secreted protease MfSAP1 regulates cell dispersal and exacerbates skin inflammation	9
S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surger	9
P348 tRNA modifications in Candida virulence	9
Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia	9
S8.3d Characterization of glycosylphosphatidylinositol-linked aspartyl proteases in Candida glabrata: Role in pathogenicity	9
Antibodies against Histoplasma capsulatum and Aspergillus fumigatus among chronic TB patients in Indonesia: a cross-sectional study	9
Mycology laboratory diagnostic capacity for invasive fungal diseases in public hospitals in Vietnam	9
S10.5c Insight into the role of secondary metabolism in the pathogenesis of Scedosporium apiospermum	9
Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens Lis	9
Predicting intracranial involvement: Unveiling perineural spread in COVID-19-associated mucormycosis, a novel phenomenon	8
S5.1d Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis	8
P303 An unusual case of isolated gluteal abscess	8
P291 Aspergillosis: another force to reckon with during COVID-19 times	8
Identification and antifungal susceptibility profile of uncommon yeast species at Fattouma Bourguiba University Hospital in Tunisia	8
P345 The relationship between virulence of Candida albicans and environmental oxygen concentration	8
Antifungal efficacy of natural antiseptic products against Candida auris	8
P225 Subcutaneous phaeohyphomycosis by Phaeoacremonium species in a renal transplant recipient	8
P113 Expression profile of ABC and MFS multi-drug transporter genes in terbinafine- and fluconazole-resistant Trichophyton spp.	8
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients	8
P420 Fungal detection by means of HCR using 2D-Covalent Organic Framework Nanosheet	8
P183 Monitoring of candida colonization in the respiratory tract of COVID-19 cases	8
P114 Clinical and microbiological spectrum of dermatophytosis from a tertiary care institute	8
Whole genome characterization of Trichophyton indotineae isolated in Singapore	7
Detection and genotyping of zoonotic microsporidia in the endangered Iberian lynx (Lynx pardinus)	7
S8.1b Is a search and destroy strategy still feasible for Candida auris in South Africa?	7
Management of disseminated histoplasmosis in a high-complexity clinic in Cali, Colombia	7
S6.3d Candida albicans commensalism in the oral mucosa is favored by limited virulence and metabolic adaptation	7

P411 Genus specific real-time PCR-a promising technique for rapid diagnosis of fungal keratitis	7
C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan	7
Opaque cell-specific proteome ofCandida albicansATCC 10231	7
Aspergillus sensitisation detection using point-of-care lateral flow assay in moderate to severe asthma	7
S2.4d Combination antifungal effects of eugenol with voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares	7
P435 Evaluation of remote triazole capillary blood testing to facilitate remote therapeutic drug monitoring (TDM): A validation study	7
Susceptibility testing of Prototheca bovis isolates from cases of bovine mastitis using the CLSI reference broth microdilution method and the Sensititre YeastOne colorimetric panel	7
P193 Candidemia in coronavirus disease 2019 patients in a university hospital in Buenos Aires, Argentina	7
Evaluation of the PneumoGenius® PCR assay for the diagnosis ofPneumocystispneumonia and the detection ofPneumocystisdihydropteroate synthase mutations in respiratory samples	7
S4.1d In vitro activity of eight antifungals against 3343 filamentous pathogenic fungi collected during 18 years at the French National Reference Center for invasive mycosis and antifungals	7
S9.5c Malassezia-host interactions and the Il-23/17 axis	7
Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality	7
Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia	7
P256 A rare case of co-infection with Nigrospora oryzae with mucormycosis in an immunocompromised post-COVID patient	6
P118 Pentraxin-3 interacts with Aspergillus fumigatus conidia to regulate pro-inflammatory cytokine production	6
Association of semi-quantitative cryptococcal antigen results in plasma with subclinical cryptococcal meningitis and mortality among patients with advanced HIV disease	6
Zoonotic Enterocytozoon bieneusi genotypes in free-ranging and farmed wild ungulates in Spain	6
Evaluation of a commercial Histoplasma antigen detection enzyme immunoassay for the follow-up of histoplasmosis treatment in people living with HIV from Argentina	6
Risk factors for COVID-19 associated mucormycosis in India: A case control study	6
P166 Traumatic implantation keratitis with Schizophyllum commune in Central India	6
S5.4d Agrochemicals potentiate multidrug resistance and alter virulence in Cryptococcus neoformans via hitch-hiking effect of aneuploidy	6
P313 A retrospective analysis of COVID-19 - associated Mucormycosis in a tertiary care center in Northern India	6
Clinical and imaging characteristics of pulmonary cryptococcosis: a comparative analysis of 118 non-AIDS patients in China	6
Molecular typing and antifungal susceptibility of clinical isolates of Cryptococcus neoformans and Cryptococcus gattii species complexes from the National Invasive Fungal Surveillance Ne	6
Diagnostic accuracy of a novel lateral flow assay for histoplasmosis	6
S3.5a Contamination in sand and water of sea, lakes, and river beaches: Risk factor for fungal human disease	6
P131 Optimization of MTT assay protocol in Pythium insidiosum zoospores incubated together with neutrophils	6
P018 Susceptibility profile of Candida albicans causing bloodstream infections against azole antifungals over 5 years: A prospective observational study	6
Clinical characteristics and outcome of invasive fungal sinusitis in children with hematological malignancies	6
Evaluation of interleukin-8 levels in the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies	6
A practical approach to investigating nosocomial acquisition of Aspergillus	6
P223 First case of Candida auris candidemia in Manipur, Northeast India	5
P501 Aspergillus fumigatus complicates one third of the patients with suspected bronchial asthma or pulmonary tuberculosis: Clinical validation of indigenously developed diagnostic kits	5
P438 Epidemiology, risk factor analysis and management of invasive Candida auris infections in tertiary care hepatobiliary center in India	5
P364 Quantitative monitoring of Aspergillus fumigatus mycelial growth by optical density	5
P372 Deciphering transcript isoform switching and utilization in mature biofilm of Candida glabrata through a global transcriptomic approach	5
Molecular detection of Enterocytozoon bieneusi in bats from Portugal	5
Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study	5
Evaluation of an in-house pan-Malassezia quantitative PCR in human clinical samples	5
Dual quantitative PCR assays for the rapid detection of Trichophyton indotineae from clinical samples	5
Biochemical characterization and analysis of gene expression of an α-mannosidase secreted by Paracoccidioides brasiliensis	5
P273 Diagnostic dilemmas in Pneumocystis pneumonia in case of long COVID -19	5
P233 COVID-19-a ssociated Mucormycosis: an experience of invasive fungal sinusitis from a tertiary care referral center in Northern India	5
P502 Mycology lab of the future—slants to sequencing	5
P414 Diagnostic allele-specific PCR for the identification of Candida auris clades and common resistance mutations	5
P432 Detection of erg11 gene mutation in fluconazole resistant Candida albicans isolates	5
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis–a two-centre observational study	5
Identification of four compounds from the Pharmakon library with antifungal activity against Candida auris and species of Cryptococcus	5
Antifungal prescribing in neonates: Using national point prevalence survey data from Australia	5
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility	5
P391 Research on molecular diagnostic methods and clinical application of common pathogenic dermatophytes in tinea capitis	5
S7.4a Vaccine-inducing lung resident CD4 + memory T cells are protective against Cryptococcus gattii infections	5
P206 Phenotypic and molecular characterization of emerging Basidiomycete Schizophyllum commune isolated from clinical samples from India	5
P486 Disseminated Cryptococcosis diagnosed on fine needle aspiration cytology	5
P334 Fungal infections in patients with COVID-19 in 1-year pandemic 2020-2021 from Cote d'Ivoire	5
P068 Inhibition of Candida glabrata biofilm using the combination of a novel antifungal cyclic lipopeptide and azole: An in vitro synergistic approach	5
A diverse spectrum of mycoses histologically diagnosed in Ghana: Insights from a 10-year retrospective study	5
Exposure to itraconazole influences the susceptibility to antifungals, physiology, and virulence of Trichophyton interdigitale	5
Significance of differential expression profiles of ABC transporters in azole susceptibility between Cryptococcus gattii VGI and VGII strains	5
Thanks to Reviewers	5
P110 AIRE gene mutation predisposing chronic mucocutaneous Candidiasis in two kids from a Chinese family	5
Coccidioidesspp. exposure among military working dogs in endemic regions of the United States	5
P395 Clinical utility of semi-nested conventional PCR for diagnosis of mucormycosis in fresh clinical samples	4
P213 Lasiodiplodia theobromae: an emerging human pathogen	4
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022	4
KL-6 as a predictor of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) and mortality in critically ill COVID-19 patients: A single-center retrospective cohort study	4
Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries	4
Epidemiology of candidemia during COVID-19 pandemic era in a teaching hospital: A non-concurrent cohort study	4
P078 Baseline antifungal usage patterns and knowledge regarding management of invasive fungal infections as a part of a multidisciplinary antifungal stewardship (AFS) program	4
P032 Efficacy of novel azole compounds (ATTAF-1 and ATTAF-2) against Candida albicans in a murine model of invasive Candidiasis	4
P294 A descriptive study of Trichosporon fungemia cases from tertiary care center from north India	4
Mucorales: A systematic review to inform the World Health Organization priority list of fungal pathogens	4
Post-COVID-19 rhino-orbito-cerebral mucormycosis—A clinico-mycological study from North India	4
Comparison of PneumID real-time PCR assay with Amplex eazyplex LAMP assay for laboratory diagnosis of Pneumocystis jirovecii Pneumonia	4
S9.4c Diverse environmental inputs mediate changes in β-glucan exposure at the Candida albicans cell surface thereby influencing tissue colonisation during systemic infection	4
P337 Species distribution and biofilm profile of Candida isolated from clinical specimens at a tertiary care hospital in India	4
P217 Pelvic mycoses— an unusual presentation of Rhizopus arrhizus in an ommunocompetent patient	4
Vaginal homeostasis features of Vulvovaginal Candidiasis through vaginal metabolic profiling	4
Mortality patterns in candidemia: Insights from a multispecies analysis using a global research network	4
S6.2d Dermatophytosis due to Trichophyton erinacei caused by contact with African hedgehogs as family pets	4

P041 Preliminary evaluation of gradient concentration strips for detection of terbinafine resistance in Trichophyton spp.	4
P171 Pneumocystis Jirovecii Pneumonia in non-HIV immunosuppressed patients: Acase series	4
P135 Immunological correlation with clinicomycological aspects of fungal rhinosinusitis during COVID-19 pandemic	4
P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study	4
Value of qPCR in the screening strategy for Candida auris	4
P211 Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units	4
Combining urine antigen and blood polymerase chain reaction for the diagnosis of disseminated histoplasmosis in hospitalized patients with advanced HIV disease	4
P326 DNA replication initiator proteins stabilize the kinetochore in the human fungal pathogen Cryptococcus neoformans	4
P154 Fungal spore count in a tertiary care hospital in Mumbai, India	4
P328 An overexpression screen identifies Csa25 as a novel cellular morphogenesis regulator in the human fungal pathogen Candida albicans	4
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis	4
S9.1d Chronic pulmonary aspergillosis in post-TB and retreatment TB patients in Lagos, Nigeria	4
Routine laboratory screening for cyp51a-related azole resistance in Aspergillus fumigatus using Etest: Concordance with gene sequencing	4
P057 All- cause mortality in patients with invasive Candidiasis or candidemia from an interim analysis of a Phase 3 Open-label Study (FURI)	4
P317 Phaeohyphomycosis caused by Phialophora verrucosa in a patient with CARD9 mutations	4
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections	4
S1.5d Spectrum of etiological agents of mycotic keratitis: A n 11- year review	4
P299 A clinicomycological study of suspected mucormycosis in post-COVID patients attending a tertiary care hospital	4
Cryptococcosis in domestic and wild animals: A review	4
Aspergillus fumigatus—a systematic review to inform the World Health Organization priority list of fungal pathogens	4
Madurella mycetomatis grains within a eumycetoma lesion are clonal	3
Metabolic and morphostructural plasticity of environmental and animal strains of Nannizzia gypsea	3
Fungal yield from sterile specimens	3
P370 Low rate of Sporothrix spp. recovery from storage in mineral oil: along period study	3
P075 Initial results of an international effort in screening new agents against Candida auris	3
P458 Comparison of PCR protocols for detecting Histoplasma capsulatum and Coccidioides spp. DNA through a multicenter study	3
S1.4d Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with cryptococcosis	3
P174 Prevalence and outcomes of patients with COVID - associated mucormycosis (CAM): A case series	3
P268 Laryngeal Mucormycosis: does mucor take the voice away?	3
A systematic review on distribution and antifungal resistance pattern ofCandidaspecies in the Indian population	3
Talaromyces marneffei, Coccidioides species, and Paracoccidioides species—a systematic review to inform the World Health Organization priority list of fungal pathogens	3
Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis	3
Malassezia gallinae sp. nov., a new basidiomycetous yeast species isolated from skins of chickens	3
Natural history of pulmonary coccidioidomycosis: Further examination of the VA-Armed Forces Database	3
P251 Disseminated Histoplasmosis in a Ghanaian HIV Patient: Role of Urine Histoplasma Antigen Testing in Rapid Diagnosis	3
P371 The relation of mating type (MAT) preference and source in the opportunistic pathogen Talaromyces marneffei	3
S10.5a Fungal respiratory infections in cystic fibrosis patients in the Middle East	3
Gastrointestinal tract Candida spp colonization shows mostly a monoclonal pattern: an intra-patient pilot study	3
Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis	3
P219 Fungal keratitis caused by Pseudallescheria boydii: Clinical and mycological characteristics	3
P484 Expanding VGVI—evidence for distinct Cryptococcus gattii (decagattii) endemic to the American Southwest	3
A Falciformispora senegalensis grain model in Galleria mellonella larvae	3
The Argentinian landscape of mycological diagnostic capacity and treatment accessibility	3
P269 Managing prosthetic valve endocarditis due to Sarocladium kiliense: Finding a way through uncertainties	3
The Billirud Mill Blastomycosis Outbreak: Comparison to Historical Controls	3
P417 Evaluation of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)-Bruker Biotyper Sirius for identification of invasive molds	3
P383 ‘It's not Fungus, its Nocardia’—an elementary diagnostic challenge for draining sinus on abdominal wall (rare): a case report	3
Evaluation of formic acid sandwich (FA-sandwich): A pretreatment method for filamentous fungi, for the identification of clinically relevant filamentous fungi by two MALDI-TOF MS systems	3
High histoplasmosis incidence in kidney transplant recipients in Santa Fe city, Argentina	3
P162 Parinaud's Oculoglandular Syndrome as an atypical manifestation of sporotrichosis in Brazil	3
P138 A decade of cat-transmitted sporotrichosis (CTS) in a tertiary hospital from Curitiba, southern Brazil (2011-21)	3
P167 Fungemia in neonatal ICU of a pediatric hospital in NE India	3
P427 The value of nasal and oral clinical examination in febrile neutropenic patients for initiating anti-fungal therapy as a preemptive method	2
Comparison of coccidioidal complement fixation and quantitative immunodiffusion serology at a reference laboratory	2
S6.2b In vitro susceptibility testing of dermatophytes: toward standardization	2
Geraniol inhibits both planktonic cells and biofilms of the Candida parapsilosis species complex: Highlight for the improved efficacy of amphotericin B, caspofungin and fluconazole plus Geranio	2
P240 Candida nivariensis infection in South East Asia: series of case reports from Selayang Hospital, Malaysia and South East Asia Region	2
S1.5b The burden of mycotic keratitis in West Africa	2
Comparison of broth microdilution and Etest® methods for susceptibility testing of amphotericin B in Candida auris	2
P151 Molecular epidemiology of environmental strains of Cryptococcus isolated from Varanasi, Uttar Pradesh, India	2
Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens	2
Correction to: Candida albicans—A systematic review to inform the World Health Organization Fungal Priority Pathogens List	2
Detection of pan-azole resistant Aspergillus fumigatus in horticulture and a composting facility in Belgium	2
S8.3c Cell wall glycans as targets for the development of new antifungals	2
P054 Two effects of curcumin to Candida albicans	2
P098 Human protothecosis: Acase report in Northeastern Brazil	2
S4.3b Candida glabrata-host interactions	2
P426 Interleukins—a non-invasive biomarker for invasive fungal sinusitis	2
The need for fast and accurate detection of dermatomycosis	2
P106 A dermoscopic finding of Tinea capitis caused by Microsporum canis	2
S8.2a Trends in epidemiology of pediatric Candida infections	2
P259 Rare presentations of Cryptococcosis: a case series	2
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection	2
P425 Approach to identify and isolate C. dubliniensis in laboratory and comparison of various methods for same	2
Performance of Mucorales spp. qPCR in bronchoalveolar lavage fluid for the diagnosis of pulmonary mucormycosis	2
P176 Basidiobolus meristosporus — anew species on the block!	2
Invasive aspergillosis caused by cryptic species in transplant recipients: A review	2
S7.3d Environmental surveillance of Aspergillus fumigatus in Dutch agricultural crops	2
P029 Synergic effect of deferoxamine combined with fluconazole against fluconazole-resistant Candida Spp. through inhibited Cek1 MAPK signaling pathway	2
P044 Demonstration of the yeasticidal efficacy of povidone-iodine-based commercial antiseptic solutions against Candida auris	2
Molecular detection and species identification of dermatophytes by SYBR-Green real-time PCR in-house methodology using hair samples obtained from dogs and cats	2
P195 Factors related to outcome of bloodstream infections due to Candida parapsilosis complex: A single center observation study from Central India	2
P442 Bacterial and fungal infection in COVID-19 diagnosed cases in a tertiary care ICU setting in the wake of second wave in Kolkata, India	2
Histoplasmaantigens as novel players for the development of new enzyme immunoassays for the serodiagnosis of histoplasmosis: A comparative study of their analytical performance	2
P320 Ten cases of tinea incognito due to Trichophyton rubrum, and literature review on the pathogenic characteristics	2
P204 Secondary organizing pneumonia caused by Aspergillus flavus in immunocompromised patients	2
P231 The first case of neonatal fungemia caused by Aureobasidium melanogenum	2
P124 Cryptococcus neoformans-and Cryptococcus gattii-specific antibodies vary among children and adults with cryptococcosis and healthy from Colombia	2
P367 Candida sepsis in neonates a neglected pathogen: study from neonatal intensive care unit tertiary care hospital	2
Molecular epidemiology of seborrheic dermatitis/dandruff associated Malassezia species from northern India	2
P242 Autochthonous cases of Madura foot from Jodhpur, Western Rajasthan, India	2
S8.3b How fungal cell wall glycans modulate the activation of platelets ?	2
Retracted: P495 Contamination of wind instruments: A potential threat to musicians	2
Evidence of anti-Hcp100 antibodies in COVID-19 critically ill patients with detectable anti-histoplasmin antibodies in a highly endemic area for histoplasmosis	2
P051 A case of recalcitrant sporotrichosis by infection of Sporothrix globosa	2